1 / 81

UK ePharmacy Market Analysis Sample Report

This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. To get a detailed report, contact us at - info@insights10.com

Insights4
Télécharger la présentation

UK ePharmacy Market Analysis Sample Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on UK ePharmacy Market Analysis Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the UK ePharmacy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the UK ePharmacy Market, and offers unmatched value, accuracy, and expert insights

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on UK ePharmacy Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 12-24 1. ePharmacy Overview 1.1. Overview 1.2. UK Overview 1.3. Economic Overview: UK 1.4. ePharmacy Market in UK 1.5. Healthcare Services Market in UK 1.6. Healthcare Scenario in UK 1.7. Health Insurance Coverage: UK 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 25-29 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on UK ePharmacy Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. By Product Type 2.2.2. By Type 30-34 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Increasing User Penetration of ePharmacy 3.1.2. Accessibility and Convenience 3.1.3. Increasing e-commerce Platform 3.2. Market Restraints 3.2.1. Data Breaches and Cyberthreats 3.2.2. Lack of Specific Legislative Framework 3.2.2. Prescription Verification 5 A Sample Report on UK ePharmacy Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 35-45 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. Pharmacy2u 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. LloydsPharmacy 4.2.2.1. Overview 4.2.2.2. Product Applications & Services 6 A Sample Report on UK ePharmacy Market Analysis I Confidential

  7. Table of Content CONTENT PG. NO. 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. Chemist4U 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. The Independent Pharmacy 4.2.4.1. Overview 4.2.4.2. Product Applications & Services 7 A Sample Report on UK ePharmacy Market Analysis I Confidential

  8. Table of Content CONTENT PG. NO. 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. AYP Healthcare 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Well Pharmacy 4.2.6.1. Overview 4.2.6.2. Product Applications & Services 8 A Sample Report on UK ePharmacy Market Analysis I Confidential

  9. Table of Content CONTENT PG. NO. 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Superdrug Online Doctor 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. e-Surgery 4.2.8.1. Overview 4.2.8.2. Product Applications & Services 9 A Sample Report on UK ePharmacy Market Analysis I Confidential

  10. Table of Content CONTENT PG. NO. 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. Simple Online Pharmacy 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. MedExpress 4.2.10.1. Overview 4.2.10.2. Product Applications & Services 10 A Sample Report on UK ePharmacy Market Analysis I Confidential

  11. Table of Content CONTENT PG. NO. 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 46-53 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 5.4 Reimbursement Process – Medicare 5.5 Reimbursement Process - Medicaid 54-59 6. Methodology & Scope 11 A Sample Report on UK ePharmacy Market Analysis I Confidential

  12. UK ePharmacy Market Analysis 1. ePharmacy Overview

  13. Overview of Global ePharmacy Trends Top 10 ePharmacy Trends Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Increased Online Presence Increased online presence of traditional and digital-only e- pharmacies Prescription Delivery Services Offering prescription delivery services for convenience and accessibility In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ Mobile Applications Growing focus on mobile applications for convenient access to e-pharmacy services. Expanded Product Range Diversifying product range beyond medications to include health and wellness items Personalization and Customization Utilizing customer data for personalized recommendations and tailored healthcare solutions AI-Powered Chatbots AI-powered chatbots for real-time customer support and healthcare information In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Telehealth and Remote Consultations Integration of telehealth services for remote consultations with healthcare professionals Digital Health Records Integration of digital health records for easy access to medical history and prescriptions 13 A Sample Report on UK ePharmacy Market Analysis I Confidential

  14. 1.1 Statistics at a Glance: The Burden of ePharmacy in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR UK UK Market ~$XX Bn Market ~Market Size of $XX Bn 14 A Sample Report on UK ePharmacy Market Analysis I Confidential

  15. 1.2 UK Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 6.73 crores Is the total population of UK in 2021 $31.3 Mn Gross domestic product (GDP) of UK In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 40.7 Is the median age in UK $46,510.28 GDP per capita of UK 15 A Sample Report on UK ePharmacy Market Analysis I Confidential

  16. 1.3 Economic Overview: UK Population of UK, (2020-2030) GDP of UK, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ 16 A Sample Report on UK ePharmacy Market Analysis I Confidential

  17. 1.4 Overview of ePharmacy in UK Highlights of ePharmacy in UK Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ US$0.89 Bn Is projected online pharmacy revenue in UK in 2023 39.35% Is the user penetration of e Pharmacies in 2023 in UK In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in UK ▪ 47.14% Is the expected user penetration of ePharmacy in UK by 2027 US$33.07 Is the expected average revenue per user (ARPU) of ePharmacy in UK In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on UK ePharmacy Market Analysis I Confidential

  18. 1.5 Healthcare Services in UK UK Healthcare Services Market Forecast, 2022-2030 (in $Bn) XX XX XX XX XX XX XX XX XX 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall healthcare services market in UK, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on UK ePharmacy Market Analysis I Confidential

  19. 1.6 Healthcare Scenario in UK ePharmacy Development Process: The process of developing a ePharmacy drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the ePharmacy drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating ePharmacy Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on UK ePharmacy Market Analysis I Confidential

  20. 1.7 Health Insurance Coverage: US % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 20 A Sample Report on UK ePharmacy Market Analysis I Confidential

  21. 1.8 Budget of UK Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 21 A Sample Report on UK ePharmacy Market Analysis I Confidential

  22. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 22 A Sample Report on UK ePharmacy Market Analysis I Confidential

  23. 1.9 Mergers and Acquisitions (continued) Latest Deals In UK Amount / Duration Company Name Type Year Key Pointers Zur Rose Group announced that the group had completed the operational integration of the Medpex brand at the Heerlen facility ▪ Merger - 2022 Zur Rose partnership with Medpex BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications ▪ Acquisition - July 2022 MedKeeper strategically complements BD's existing presence in the pharmacy – where the company has pioneered solutions in compounding, logistics workflow, controlled substance management and inventory optimization.tion ▪ BD (Becton, Dickinson and Company) acquired MedKeeper 23 A Sample Report on UK ePharmacy Market Analysis I Confidential

  24. 1.9 Mergers and Acquisitions(continued) Latest Deals In UK Amount / Duration Company Name Type Year Key Pointers Merger - Acquisition - Illustrative Illustrative 24 A Sample Report on UK ePharmacy Market Analysis I Confidential

  25. UK ePharmacy Market Analysis 2. Market Size and Forecasting

  26. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption UK ePharmacy Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 UK Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 UK Market Size (Bn $) 61 74 84 87 91 95 99 106 26 A Sample Report on UK ePharmacy Market Analysis I Confidential

  27. 2.2 Snapshot of ePharmacy Market Segmentation By Product Type By Type Prescription Medicine Analgesics Over the Counter Medicine Skin Care Dental Care Cold and Flu Vitamins and Minerals Others In this section you will get an understanding of the segmentations which will cover the UK ePharmacy Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 27 A Sample Report on UK ePharmacy Market Analysis I Confidential

  28. 2.2.1 Market Segmentation: By Product Type UK ePharmacy Market Share, By Product Type (2022) Prescription medication market in UK is a significant component of the overall ePharmacy treatment market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Over the Counter Medications In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Prescription Medications, 65% Illustrative Illustrative 28 A Sample Report on UK ePharmacy Market Analysis I Confidential

  29. 2.2.2 Market Segmentation: By Type UK ePharmacy Market Share, By Type (2022) Analgesics ePharmacy market in UK is a significant component of the overall ePharmacy market ▪ Others, 12% Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Vitamins and Minerals, 10% Analgesics Clold and Flu, 15% In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Dental Care, 20% Skin Care, 38% Illustrative Illustrative 29 A Sample Report on UK ePharmacy Market Analysis I Confidential

  30. UK ePharmacy Market Analysis 3. Market Dynamics

  31. 3.1 Market growth drivers 3.1.1 In UK the user penetration of ePharmacy will be 39.35% in 2023 and is expected to hit 47.14% by 2027 ePharmacies offer the convenience of ordering medications and healthcare products online from the comfort of one's home. This accessibility appeals to individuals with busy lifestyles, limited mobility, or those living in remote areas ▪ ePharmacy Use In UK Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 31 A Sample Report on UK ePharmacy Market Analysis I Confidential

  32. 3.1 Market growth drivers 3.1.2 In the UK, ePharmacies play a crucial role in providing secure access to authentic and approved pharmaceuticals at affordable prices, with enhanced convenience through online platforms, home delivery, and improved digital payment infrastructure E-pharmacies can assist secure the provision of authentic and approved pharmaceuticals (a wide range of drugs that are safe for use) at reasonable rates (by removing intermediaries and giving discounts) and with greater ease of access (online platform, home delivery & improved digital payment infrastructure) ▪ As a result of the convenience and value they provide, E-Pharmacies are predicted to be generally embraced in UK ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 32 A Sample Report on UK ePharmacy Market Analysis I Confidential

  33. 3.1 Market growth drivers (continued) 3.1.3 Efficiency of ePharmacies in delivering low-cost medical products, and combined with the increasing penetration of e-commerce is driving the UK ePharmacy market growth. User penetration will be 83.1% in 2023 and is expected to hit 86.3% by 2027 A large patient pool globally prefers doorstep delivery of healthcare products owing to unavailability of certain medicines in retail pharmacy stores ▪ Penetration rate of e-commerce in UK Additionally, ePharmacies lower the dependency of chronically ill patients and elderly citizens towards third person for procurement of medicines and healthcare supplies. Additionally, the increasing penetration and literacy regarding internet resources are projected to boost the market sales. ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 33 A Sample Report on UK ePharmacy Market Analysis I Confidential

  34. 3.2 Market restraints 3.2.1 In the UK, ePharmacies collect and process user data, this user data also make ePharmacies vulnerable to data breaches and cyberthreats 3.2.2 In UK, there is currently no unique or specific legislative framework that solely governs the operations and practices of ePharmacies 3.2.3 In UK, implementing robust prescription verification systems while maintaining privacy can be a complex task To provide a flawless consumer experience, these online platforms rely substantially on useful insights obtained from user data (personal details, purchasing habits, etc.) As a result, this data is vulnerable to data breaches and other cyberthreats. Owing to there is no unique regime for these players, the legal system that governs the offline sale of pharmacies equally applies to E-Pharmacy To safeguard the interests of customers and to act as a backbone in encouraging growth in this sector, the government must establish a separate legislative framework for E- Pharmacies in the near future Validating prescriptions and ensuring they are genuine poses a challenge for ePharmacies Verifying prescriptions online is crucial to prevent misuse or illegal distribution of medications. Implementing robust prescription verification systems while maintaining privacy can be complex ▪ ▪ ▪ ▪ ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth 34 A Sample Report on UK ePharmacy Market Analysis I Confidential

  35. UK ePharmacy Market Analysis 4. Competitive Landscape

  36. 4.1 Major Market Share UK ePharmacy market is a highly competitive space, with many companies developing and marketing ePharmacy treatments ▪ Revenue of Major players in UK ePharmacy Market ($ Mn) Company10 Company 9 Some of the top companies in UK ePharmacy market based on revenue and market share include ▪ Company 8 Company 7 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Company 6 Company 5 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Company 4 Company 3 Company 2 Company 1 XX 36 A Sample Report on UK ePharmacy Market Analysis I Confidential

  37. 4.2 Key Company Profile Key Note: 1 Here is the list of top 10 companies which will cover in the final report ▪ Pharmacy2u 2 LloydsPharmacy Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report o Chemist4U o 4 The Independent Pharmacy o o 5 AYP Healthcare o 6 o o Well Pharmacy 7 Superdrug Online Doctor o 8 ▪ e-Surgery 9 Simple Online Pharmacy ▪ 10 MedExpress 37 A Sample Report on UK ePharmacy Market Analysis I Confidential

  38. 4.2.1 Pharmacy2U Solutions offered by Roche ▪ Pharmacy2U is one of the largest online pharmacies in the UK ▪ It operates as an online platform that provides a range of healthcare services and products ▪ Pharmacy2U's primary focus is on providing convenient access to prescription medications and healthcare advice to customers across the country ▪ They operate under the supervision of the General Pharmaceutical Council (GPhC) and follow guidelines set by the Medicines and Healthcare products Regulatory Agency (MHRA) Founded in: 1999 ➢ Mark Livingstone - Chief Executive Officer (CEO) HQ: Leeds, United Kingdom ➢ Daniel Lee - Chief Financial Officer (CFO) Type: Private ➢ Julian Harrison - Chief Commercial Officer (CCO) Revenue: $150 Mn Website: www.pharmacy2u.co.uk ➢ Andy Hornby - Chairman ePharmacy Recent Activity / Press Coverage Services Offered by Pharmacr2U April 2023, Pharmacy2U, the leading online pharmacy in the UK, announced that they will be leveraging RingCentral’s UCaaS and CCaaS services through the cloud, to offer next-level customer service in the age of digital transformation Online Prescription Ordering Medication Reminder Service Repeat Prescription Management Online Doctor Consultations NHS Prescription Service Health Information and Advice November 2022, Pharmacy2U Voted UK Number One Brand for Customer Experience By Pharmacy2U Online Doctor Service NHS Prescriptions Medication Delivery 38 A Sample Report on UK ePharmacy Market Analysis I Confidential

  39. 4.2.1 Pharmacy2U (continued) Partnerships Ecosystem Current Corporate Partners Current Clinical Trail Partners 39 A Sample Report on UK ePharmacy Market Analysis I Confidential

  40. 4.2.1 Pharmacy2U (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Pharmacy2U announced new partnership with Diabetes UK This partnership aims to help support people currently living with diabetes, as well as those at increased risk of type 2 diabetes across the UK With 4.9 Mn people living in the UK with diabetes and an estimated 13.6 million people at increased risk of developing type 2 diabetes, providing clear information and accessible guidance is crucial ▪ ▪ October 2021 Merger - ▪ Pharmacy2U partnership with Diabetes UK Illustrative Illustrative 40 A Sample Report on UK ePharmacy Market Analysis I Confidential

  41. 4.2.1 Pharmacy2U (continued) Revenues ($Bn), 2020-2030 Pharmacy2U annual revenue for 2022 was $150 Mn, a xx% increase from 2021. Pharmacy2U annual revenue for 2021 was $xx, a xx% increase from 2020. ▪ 70.9 70.3 Revenue generated by Pharmacy2U in 2022 reflects the company's continued growth and success in the healthcare industry ▪ 63.3 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 41 A Sample Report on UK ePharmacy Market Analysis I Confidential

  42. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for ePharmacy Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 42 A Sample Report on UK ePharmacy Market Analysis I Confidential

  43. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 43 A Sample Report on UK ePharmacy Market Analysis I Confidential

  44. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 44 A Sample Report on UK ePharmacy Market Analysis I Confidential

  45. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 45 A Sample Report on UK ePharmacy Market Analysis I Confidential

  46. UK ePharmacy Market Analysis 5. Reimbursement Scenario

  47. 5.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans The reimbursement scenario in the US ePharmacy market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many ePharmacy treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for ePharmacy treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for ePharmacy treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 47 A Sample Report on UK ePharmacy Market Analysis I Confidential

  48. 5.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to ePharmacy treatments by requiring insurers to cover certain preventive services, including ePharmacy screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as ePharmacy Reimbursement for New Treatments: Reimbursement for new ePharmacy treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 48 A Sample Report on UK ePharmacy Market Analysis I Confidential

  49. 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure 46.0% xx 47.7% xx xx xx 51.0% 51.8% xx Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities  Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 49 A Sample Report on UK ePharmacy Market Analysis I Confidential

  50. 5.2 Reimbursement Process The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 50 A Sample Report on UK ePharmacy Market Analysis I Confidential

More Related